2024
Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older
Ghali F, Holt S, Koehne E, Chen J, Weg E, Liao J, Zeng J, Grivas P, Hawley J, Hsieh A, Montgomery R, Wright J. Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older. Frontiers In Oncology 2024, 14: 1341655. PMID: 38812783, PMCID: PMC11133586, DOI: 10.3389/fonc.2024.1341655.Peer-Reviewed Original ResearchMuscle invasive bladder cancerPatterns of chemotherapy useRadiation therapyReceipt of chemotherapyChemotherapy useMultivariate logistic regressionConcurrent chemotherapyOverall survivalBladder cancerFactors associated with receipt of chemotherapyMaximum transurethral resection of bladder tumorNational Cancer Institute comorbidity indexTransurethral resection of bladder tumorAlternative to radical cystectomyAssociated with superior OSReceipt of concurrent chemotherapyResection of bladder tumorCurative-intent RTLow dose gemcitabineUtilization of chemotherapyLocalized bladder cancerInvasive bladder cancerFactors associated with receiptYear of diagnosisSuperior disease control
2023
The Pursuit of Intravesical and Systemic Therapies in Non–muscle-invasive Bladder Cancer: Challenges and Opportunities
Ghali F, Wright J, Grivas P. The Pursuit of Intravesical and Systemic Therapies in Non–muscle-invasive Bladder Cancer: Challenges and Opportunities. European Urology Oncology 2023, 6: 321-322. PMID: 37045706, DOI: 10.1016/j.euo.2023.03.006.Peer-Reviewed Original Research